Peter Mansell

Peter Mansell

Peter Mansell's picture

Latest posts from :

Access and Evidence

Pharma market access in Germany

Jun 11, 2012

Peter Mansell explores what Germany’s Act to Reform the Market for Medicinal...

Commercial

Pharma sales, value and payers

Jun 1, 2012

Peter Mansell explores how pharma can convincingly demonstrate value to payers

Commercial

Pharma sales and the digital rep

May 28, 2012

Peter Mansell talks to Andreas Claus Kistner, Roche’s global head of...

Commercial

Pharma marketing and lifecycle...

Feb 28, 2012

Peter Mansell investigates how lifecycle management can become a vehicle for...

Access and Evidence

Pharma and market access: How to...

Feb 20, 2012

Steven Flostrand, principal at IMS Consulting Group, on how to thrive in...

Commercial

Forecasting for licensed compounds

Oct 14, 2011

Peter Mansell examines the impact of heavier in-licensing/out-licensing traffic...

Commercial

Forecasting the future of biologics

Sep 15, 2011

Peter Mansell reports on how to balance complexity and predictability when...

Commercial

Pharma sales: KAM as a market...

Aug 9, 2011

Peter Mansell reports on why key account management (KAM) is coming into its...

Commercial

When forecasters take the floor: 6...

Jun 28, 2011

Peter Mansell queries some of pharma’s leading forecasters for their dos and...

Commercial

Managing market uncertainty: Is...

May 16, 2011

Peter Mansell explores how risk-sharing schemes can provide patient access and...

Pages